Evidence map›Paper›PMID 34501259›Full record

ReviewJournal of clinical medicine2021

The Epidemiology and Clinical Presentations of Atopic Diseases in Selective IgA Deficiency.

Izabela Morawska, Sara Kurkowska, Dominika Bębnowska, Rafał Hrynkiewicz, Rafał Becht, Adam Michalski, Hanna Piwowarska-Bilska, Bożena Birkenfeld, Katarzyna Załuska-Ogryzek, Ewelina Grywalska and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Clinical manifestation for immunoglobulin A deficiency: a systematic review and meta-analysis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Izabela MorawskaDepartment of Clinical Immunology and Immunotherapy, Medical University of Lublin, Chodźki 4a St., 20-093 Lublin, Poland.ORCID 0000-0001-9462-8779
Sara KurkowskaDepartment of Nuclear Medicine, Pomeranian Medical University, Unii Lubelskiej 1 St., 71-252 Szczecin, Poland.ORCID 0000-0001-5101-8911
Dominika BębnowskaInstitute of Biology, University of Szczecin, Felczaka 3c St., 71-412 Szczecin, Poland.ORCID 0000-0003-3689-2381
Rafał HrynkiewiczInstitute of Biology, University of Szczecin, Felczaka 3c St., 71-412 Szczecin, Poland.ORCID 0000-0002-0688-6928
Rafał BechtClinical Department of Oncology, Chemotherapy and Cancer Immunotherapy, Pomeranian Medical University of Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
Adam MichalskiDepartment of Clinical Immunology and Immunotherapy, Medical University of Lublin, Chodźki 4a St., 20-093 Lublin, Poland.ORCID 0000-0001-9598-373X
Hanna Piwowarska-BilskaDepartment of Nuclear Medicine, Pomeranian Medical University, Unii Lubelskiej 1 St., 71-252 Szczecin, Poland.
Bożena BirkenfeldDepartment of Nuclear Medicine, Pomeranian Medical University, Unii Lubelskiej 1 St., 71-252 Szczecin, Poland.
Katarzyna Załuska-OgryzekDepartment of Pathophysiology, Medical University of Lublin, Jaczewskiego 8b St., 20-090 Lublin, Poland.
Ewelina GrywalskaDepartment of Clinical Immunology and Immunotherapy, Medical University of Lublin, Chodźki 4a St., 20-093 Lublin, Poland.ORCID 0000-0002-0451-4741
Jacek RolińskiDepartment of Clinical Immunology and Immunotherapy, Medical University of Lublin, Chodźki 4a St., 20-093 Lublin, Poland.ORCID 0000-0003-4841-6120
Paulina Niedźwiedzka-RystwejInstitute of Biology, University of Szczecin, Felczaka 3c St., 71-412 Szczecin, Poland.ORCID 0000-0003-4065-3842
Medical University of Lublin · PLUniversity of Szczecin · PLPomeranian Medical University · PL

Funding

Medical University of Lublin DS460Polish National Science Centre (NCN) 2016/21/B/NZ6/02279
6 · The paper itself

Abstract

Selective IgA deficiency (sIgAD) is the most common primary immunodeficiency disease (PID), with an estimated occurrence from about 1:3000 to even 1:150, depending on population. sIgAD is diagnosed in adults and children after the 4th year of age, with immunoglobulin A level below 0.07 g/L and normal levels of IgM and IgG. Usually, the disease remains undiagnosed throughout the patient's life, due to its frequent asymptomatic course. If symptomatic, sIgAD is connected to more frequent viral and bacterial infections of upper respiratory, urinary, and gastrointestinal tracts, as well as autoimmune and allergic diseases. Interestingly, it may also be associated with other PIDs, such as IgG subclasses deficiency or specific antibodies deficiency. Rarely sIgAD can evolve to common variable immunodeficiency disease (CVID). It should also be remembered that IgA deficiency may occur in the course of other conditions or result from their treatment. It is hypothesized that allergic diseases (e.g., eczema, rhinitis, asthma) are more common in patients diagnosed with this particular PID. Selective IgA deficiency, although usually mildly symptomatic, can be difficult for clinicians. The aim of the study is to summarize the connection between selective IgA deficiency and atopic diseases.

Indexed as

allergyatopic diseasesatopyprimary immunodeficiencyselective IgA deficiency

Identifiers

PMID34501259
PMCPMC8432128
OpenAlexW3193317530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.